ommitment to delivering innovative, safe and science-backed solutions across its aesthetics portfolio.

First approved in the EU in 1999, Sculptra pioneered a new approach to volume restoration by stimulating the body’s own collagen production.1,13,14Over the past 25 years, it has evolved into a versatile treatment that delivers regenerative benefits across all three skin layers, making it the first proven regenerative biostimulator. With its expanded indication, Sculptra brings its trusted efficacy to the body, offering patients and practitioners a new opportunity to achieve holistic, full-body aesthetic care.

This material refers only to the product certified under Regulation (EU) 2017/745 (MDR). Legacy versions of the product remain available. For full product information and the Instructions for Use (IFU), visit:ttps://www.galderma.com/sites/default/files/2025-12/IFU_Sculptra_MDR.pdf

About Sculptra
Sculptra is the first proven regenerative bi
=*=*=*=*=*=
当前为第7/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页